SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D

November 30, 2023 08:43 PM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D. 

The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be included in Philips' global price book once the relevant regulatory clearance has been obtained. This will enable Philips to offer the complete package to their customers.

"We are very excited to expand our collaboration with SyntheticMR, aiming to achieve greater results with fewer resources in the field of imaging," says Ruud Zwerink, GM at Philips Healthcare. "Through our partnership, we will provide clinicians and patients with improved, immediate, and distinctive insights that have a considerable impact on diagnosis, treatment planning, and the subsequent care – a previously elusive goal."

SyMRI 3D is a next-generation imaging solution with isotropic resolution that is poised to revolutionize the field of medical imaging by introducing a myriad of innovative applications within SyMRI's post-processing solution. This advanced SyMRI 3D sequence introduces 3D resolution to quantitative values and tissue segmentations, ensuring the same level of precision in quantification as achieved with SyMRI's 2D imaging. 

SyMRI 3D enables precise volumetric estimations of brain regions, a technique commonly referred to as parcellation, which empowers clinicians to gain deeper insights into brain structure and function. Furthermore, the exceptional resolution provided by SyMRI 3D facilitates comprehensive lesion analysis, ensuring a more accurate and in-depth assessment of medical conditions.

"In joining forces with Philips on SyMRI 3D, we've achieved a pivotal milestone on our path to establishing a new standard in neuroimaging," says Ulrik Harrysson, CEO, SyntheticMR AB. "Our shared mission to enhance efficiency, elevate patient care, and drive meaningful savings in healthcare, reaffirms our commitment to revolutionize the field."

CONTACT:

For additional information, please contact Kyle Frye, CCO,  +1 (859) 512-9496 [email protected]

The following files are available for download:

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Two ASX Listed Stocks Giving Bullish Indications

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.